Biotech Breakthroughs and Unconventional Paths

This chapter explores the remarkable career of a biopharma industry leader who transitioned from surgical robotics to developing a successful blood cancer drug, Imbruvica. It highlights their unique approach to drug development, contrasting traditional practices with a more unpredictable, yet effective, strategy. The discussion also emphasizes the challenges faced in the biotech field and the evolving landscape of cancer treatments, particularly immuno-oncology.